Search

Your search keyword '"Herbert Valensise"' showing total 197 results

Search Constraints

Start Over You searched for: Author "Herbert Valensise" Remove constraint Author: "Herbert Valensise"
197 results on '"Herbert Valensise"'

Search Results

101. Role of antepartum computerized fetal heart rate analysis in the prediction of fetal distress during labor

102. Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome

103. F4. NO donors and haemodynamic changes in fetal growth restriction

104. H1. Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent pre-eclampsia

105. A5. Bed rest reduces maternal total vascular resistance and enhances fetal growth

106. F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy?

107. G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles

108. D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients

109. Screening Pregnant Women at 22-24 Weeks for Gestational Hypertension or Intrauterine Growth Retardation by Doppler Ultrasound Followed by 24-Hour Blood Pressure Recording

110. Peduncolated Mixoyd Leiomyoma: MR Imaging and Spectroscopy

111. Hypertension in pregnancy and endothelial activation: an emerging risk factor for cardiovascular disease

112. The relationshp of clinical-pathologic status and adiuvant treatment with natural hller cell activity in stage I and II endometrial carcinoma

113. Prenatal and Postnatal Imaging of Multiple Intracranial Lipomas: Report of a Case

114. Second-trimester uterine artery flow velocity waveform and oral glucose tolerance test as a means of predicting intrauterine growth retardation

115. Doppler velocimetry of the uterine artery as a screening test for gestational hypertension

116. Longitudinal Variation of Computerized Fetal Heart Rate Variability in Growth-Retarded Fetuses

117. Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine

118. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease

119. Complicanze ipertensive della gravidanza

120. Ultrasound-determined fetal subcutaneous tissue thickness for a birthweight prediction model

122. Diagnostic evaluation of women experiencing repeated in vitro fertilization failure

123. PP065. Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy in order to predict hypertensive complications

124. The computerized fetal heart rate analysis in post-term pregnancy identifies patients at risk for fetal distress in labour

125. Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle

126. Body composition during normal pregnancy: reference ranges

127. Maternal body composition at term gestation and birth weight: is there a link?

128. Absent end diastolic flow in umbilical artery and umbilical cord thrombosis at term of pregnancy

129. Left ventricular concentric geometry as a risk factor in gestational hypertension

130. Nifedipine-induced changes in body composition in hypertensive patients at term

131. Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women

133. OP01.04: Total vascular resistance is already elevated at 24 weeks' gestation in patients with subsequent complications in persisting bilateral notching of uterine artery Doppler waveforms

134. OC90: Maternal total vascular resistance and concentric geometry of the left ventricle for the identification of complicated and un complicated gestational hypertension

135. P10.19: Intrauterine growth restriction and fetal body composition

136. Circadian blood pressure patterns in pregnant women with intrauterine growth retardation

137. Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension

138. P05.28: Can we improve fetal growth acting on maternal cardiac function? A pilot study

139. OC068: Total vascular resistance as a target for pharmacological treatment of early mild gestational hypertension

140. Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG)

141. P199: Fetal subcutaneous tissue and two independent-parameter-formulas for estimating fetal weight

142. P206: Fetal growth restriction: an intrauterine self-destructive syndrome

143. Influence of neoadjuvant polychemotherapy on natural killer cell activity in patients with locally advanced cervical squamous carcinoma

144. L27. Management of non severe gestational hypertension through the modulation of total vascular resistance

146. O21. Total vascular resistance and multigate spectral doppler analysis (MSDA) as a screening tool for preeclampsia: A pilot study

147. L18. Total Vascular Resistance in complicated pregnancies

148. Reply to C Nunez

149. OC14.06: NO donors and volume expansion added to antihypertensive therapy in gestational hypertension decreases systemic vascular resistance and complications

Catalog

Books, media, physical & digital resources